Skip to main content

Table 2 Baseline data, end of treatment data and intra-individual change of items and total score of the Bronchitis Severity Scale (BSS). Possible maximum for individual items is 4, for total score 20. Data are mean ± SD. Numbers of responders for a given item differed somewhat between items but ranged between 92 and 99% in all cases

From: Characterization of differential patient profiles and therapeutic responses of pharmacy customers for four ambroxol formulations

  ER capsules Adult syrup Pediatric syrup Pastilles Total
Baseline data
 Cough 2.9 ± 0.7 2.9 ± 0.8 2.9 ± 0.7 2.7 ± 0.7 2.8 ± 0.7
 Sputum 2.2 ± 1.0 2.1 ± 1.0 1.9 ± 1.0 2.0 ± 1.0 2.0 ± 1.0
 Rattles 1.8 ± 1.1 1.9 ± 1.1 1.6 ± 1.1 1.4 ± 1.1 1.7 ± 1.1
 Chest pain while coughing 1.8 ± 1.1 1.8 ± 1.1 1.4 ± 1.1 1.6 ± 1.1 1.6 ± 1.1
 Dyspnea 1.5 ± 1.1 1.5 ± 1.2 1.0 ± 1.0 1.1 ± 1.1 1.3 ± 1.1
 Total score 10.0 ± 3.8 10.1 ± 3.9 8.7 ± 3.5 8.8 ± 3.8 9.4 ± 3.8
Post-treatment data
 Cough 1.4 ± 0.7 1.3 ± 0.7 1.2 ± 0.6 1.2 ± 0.7 1.3 ± 0.7
 Sputum 1.4 ± 1.0 1.3 ± 1.0 1.1 ± 0.9 1.1 ± 1.0 1.2 ± 1.0
 Rattles 0.6 ± 0.8 0.6 ± 0.8 0.4 ± 0.7 0.5 ± 0.7 0.5 ± 0.7
 Chest pain while coughing 0.6 ± 0.8 0.6 ± 0.8 0.3 ± 0.6 0.5 ± 0.7 0.5 ± 0.7
 Dyspnea 0.5 ± 0.7 0.5 ± 0.7 0.3 ± 0.6 0.4 ± 0.6 0.4 ± 0.7
 Total score 4.5 ± 3.0 4.1 ± 3.1 3.3 ± 2.5 3.7 ± 2.9 3.9 ± 2.9
Intra-individual change
 Cough −1.5 ± 0.9 −1.6 ± 0.9 −1.7 ± 0.8 −1.5 ± 0.8 −1.6 ± 0.9
 Sputum −0.8 ± 1.4 −0.9 ± 1.4 −0.8 ± 1.3 −0.8 ± 1.3 −0.8 ± 1.3
 Rattles −1.2 ± 1.0 −1.3 ± 1.0 − 1.2 ± 1.0 − 0.9 ± 0.9 −1.2 ± 1.0
 Chest pain while coughing −1.2 ± 1.1 −1.3 ± 1.0 − 1.0 ± 1.0 −1.1 ± 0.9 − 1.2 ± 1.0
 Dyspnea −1.0 ± 1.0 − 1.0 ± 0.9 − 0.7 ± 0.9 − 0.8 ± 0.9 − 0.9 ± 0.9
 Total score −5.5 ± 3.8 −6.0 ± 3.8 −5.4 ± 3.3 −5.2 ± 3.3 −5.5 ± 3.6